Patton Albertson Miller Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,640
Closed -$403K 224
2022
Q3
$403K Hold
1,640
0.09% 164
2022
Q2
$406K Hold
1,640
0.08% 172
2022
Q1
$543K Hold
1,640
0.09% 168
2021
Q4
$589K Hold
1,640
0.1% 167
2021
Q3
$534K Hold
1,640
0.1% 163
2021
Q2
$512K Hold
1,640
0.12% 139
2021
Q1
$523K Hold
1,640
0.13% 139
2020
Q4
$529K Hold
1,640
0.13% 137
2020
Q3
$454K Hold
1,640
0.13% 147
2020
Q2
$396K Hold
1,640
0.12% 158
2020
Q1
$238K Hold
1,640
0.08% 195
2019
Q4
$280K Sell
1,640
-1,600
-49% -$297K 0.07% 202
2019
Q3
$576K Hold
3,240
0.16% 140
2019
Q2
$619K Buy
+3,240
New +$860K 0.18% 139
2019
Q1
Sell
-3,240
Closed -$1.15M 120
2018
Q4
$1.15M Hold
3,240
0.61% 53
2018
Q3
$1.14M Hold
3,240
0.58% 59
2018
Q2
$1.32M Buy
+3,240
New +$1.17M 0.67% 54

Other funds holding ABMD

Patton Albertson Miller Group's ABMD Position: Q4 2022 in Review

Patton Albertson Miller Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,640 shares — an estimated $403K sold.

Patton Albertson Miller Group first reported a position in ABMD in Q2 2018 and held it in 17 quarters. The position peaked at $1.32M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Patton Albertson Miller Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Patton Albertson Miller Group sold 1,640 Abiomed Inc shares in Q4 2022, an estimated $403K.
  • Patton Albertson Miller Group first reported a position in Abiomed Inc in Q2 2018 and held it in 17 quarters.
  • Patton Albertson Miller Group's Abiomed Inc position peaked at $1.32M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Patton Albertson Miller Group's 13F filing for Q4 2022, filed 23 Jan 2023.